Skip to content

It looks like we may have content for your preferred language. Would you like to view this page in English?

Represented DiaCarta, Ltd. in its business combination with HH&L Acquisition Co.

Represented DiaCarta, Ltd., a precision molecular diagnostics company and leading developer of novel oncology and infectious disease tests., in its business combination with HH&L Acquisition Co., a special purpose acquisition company.